About the Benign Tumors Session
Benign tumors, though non-cancerous, are a crucial area of study in cancer research. Understanding their biology can shed light on malignant tumor formation and progression. Unlike cancerous tumors, benign growths do not invade nearby tissues or spread to distant parts of the body. However, they can still cause health issues depending on their size and location. Research focuses on deciphering the molecular mechanisms underlying benign tumor development, which can reveal insights into cell proliferation, differentiation, and genetic mutations. Additionally, studying benign tumors aids in the development of diagnostic tools and treatment strategies, as some benign conditions may mimic cancerous ones. Ultimately, unraveling the complexities of benign tumors contributes significantly to advancing cancer detection, prevention, and management.
Topics Covered in Benign Tumors
Noninvasive Growth
Malignant Transformation
Differential Diagnosis
Mass Effect Symptoms
Surgical Excision
Fibroids & Meningiomas
Related Scientific Sessions at CIOC 2027
Why Attend the Benign Tumors Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Benign Tumors work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Benign Tumors research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Benign Tumors track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Benign Tumors Conference 2027 — FAQs
What is the Benign Tumors track at CIOC 2027?
The Benign Tumors track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Benign Tumors. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Benign Tumors sessions?
Cancer researchers and clinicians, educators and students with an interest in Benign Tumors are all welcome — whether presenting or attending.
Can I present my research in the Benign Tumors track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Benign Tumors sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Benign Tumors track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.